Patent Assignment
Reel/Frame 043041/0950
Security Interest
Recorded: 2017-07-19
Pages: 9
Assignor
SPROUT PHARMACEUTICALS, INC.
Executed: 2017-07-17
Assignee
THE BANK OF NEW YORK MELLON
101 BARCLAY STREET, FLOOR 7E, NEW YORK, NEW YORK, 10286
Covered Properties
(19)
New benzimidazolone derivatives having mixed serotonin and dopamine receptors affinity
Patent:
6,281,218 →
Application:
09/634,120 →
N,N'-Disubstituted Benzimidazolone Derivatives with Affinity at the Serotonin and Dopamine Receptors
Benzimidazolone Derivatives Displaying Affinity at the Serotonin and Dopamine Receptors
Stable Polymorph of Flibanserin
A Method of Treating Female Hypoactive Desire Disorder with Flibanserin
Treating Sexual Desire Disorders with Flibanserin
Stable Polymorph of Flibanserin
Use of Flibanserin in the Treatment of Obesity
Benzimidazolone Derivatives for the Treatment of Premenstrual and Other Female Sexual Disorders
Sulfated Benzimidazolone Derivatives Having Mixed Serotonine Receptor Affinity
Use of Flibanserin in the Treatment of Obesity
Method of Using Flibanserin for Neuroprotection
Application:
14/319,420 →
Publication:
US 2015/0057290
Salts
Treatment of Vasomotor Symptoms
Treating Sexual Desire Disorders with Flibanserin
Flibanserin for the Treatment of Urinary Incontinence and Related Diseases
Pharmaceutical compositions containing flibanserin
Application:
14/867,779 →
Publication:
US 2016/0095819
Use of a Polymorph of Flibanserin for Treating Disease
Application:
14/876,235 →
Publication:
US 2016/0095855
Treating Sexual Desire Disorders with Flibanserin
Related Assignments
(7)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Agreement
Dec 21, 2015
From: SPROUT PHARMACEUTICALS, INC., AS GRANTOR; UNILENS VISION INC., AS GRANTOR; COMMONWEALTH LABORATORIES, LLC, AS GRANTOR; SYNERGETICS USA, INC., AS GRANTOR
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 037357/0490 →
Security Interest
Feb 25, 2021
From: SPROUT PHARMACEUTICALS, INC.
To: GOODRICH, BRAXTON; WHITEHEAD, ROBERT
Reel/Frame 055407/0810 →
Corrective Assignment to Correct the Typographical Error in the Assignment Us Patent 10,098,987 Should Have Been Identified as 10,098,876 and Us Patent 8,785,485 Should Have Been Identified as 8,785,458. Which Incorrectly Identified Previously Recorded on Reel 055407 Frame 0810. Assignor(S) Hereby Confirms the Security Interest.
Mar 1, 2021
From: SPROUT PHARMACEUTICALS, INC.
To: GOODRICH, BRAXTON; WHITEHEAD, ROBERT
Reel/Frame 055467/0791 →
Release of Security Interest in Specified Patents
Sep 9, 2022
From: THE BANK OF NEW YORK MELLON
To: SPROUT PHARMACEUTICALS, INC.
Reel/Frame 061402/0236 →
Release of Security Interest in Specified Patents
Sep 9, 2022
From: BARCLAYS BANK PLC
To: SPROUT PHARMACEUTICALS, INC.
Reel/Frame 061402/0194 →
Security Interest
Apr 13, 2023
From: SPROUT PHARMACEUTICALS, INC.
To: HOLLAND, ANNE; MCGLOTHLIN, SANDRA
Reel/Frame 063320/0136 →
Release of Security Interest
Apr 8, 2025
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: SOLTA MEDICAL, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED); SALIX PHARMACEUTICALS, INC.
Reel/Frame 070778/0199 →